Eris Lifesciences Ltd (NSE:ERIS) reported a 28% year-on-year growth in consolidated operating revenue for Q4, reaching INR 705 crores. The company achieved a significant 70% year-on-year growth in ...

Eris Lifesciences (ERIS) posted lower-than-expected 4QFY25 performance. This has been largely due to a marginal slip in the execution, particularly in the insulin revenue. Organic base business ...

Eris Lifesciences Ltd (NSE:ERIS) reported a 28% year-on-year growth in consolidated operating revenue for Q4, reaching INR 705 crores. The company achieved a significant 70% year-on-year growth in ...

Avalanche, Helix and Faculty Group have launched Fusion, a new blockchain ecosystem aimed at driving real-world adoption through modular infrastructure tailored to specific industries. Built on ...

Eris Lifesciences, a leading Indian branded formulations manufacturing company, in its Q4 FY25 garnered revenues at Rs. 705 crore, up by 28% YoY. In FY 25 it generated its total income of Rs. 2,894 ...

Ripple, the creator of cryptocurrency XRP (XRP), launched cross-border blockchain payments in the United Arab Emirates (UAE), a development that could spur the adoption of cryptocurrency in a ...

That same drive for innovation and economic opportunity must now be channeled into the next technological revolution: blockchain. Much of the public conversation around blockchain has been limited to ...

Eris Lifesciences Limited was incorporated on January 25, 2007. Subsequently, the name of the company was changed to Eris Lifesciences Private Limited on February 9, 2007. Further, the Company was ...

Gilmour Space Technologies has been performing final system checks before launching its homegrown Eris rocket. The vehicle was poised to become the first orbital launch from Australian soil by a ...